Valorigo
PrivateLast Round
Seed
Jan 10, 2024
Total Funding Raised
$104,500
Company Overview
Valorigo is a healthtech company that provides a pharmacy infrastructure platform designed for inventory reliability and patient access in Africa.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Patient Engagement, Mobile Commerce, Retail Technology
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valorigo Comparables
Compare Valorigo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmarun | 78% | |
| Chefaa | 72% | |
| Zuri Health | 70% | |
Valorigo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 10, 2024 | ||||
| Grant | Sep 29, 2022 |
Valorigo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| World Health Organization Regional Office for Africa | Grant |
| AUDA-NEPAD | Grant |
| Gates Foundation | Grant |
| Digital Africa | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 10, 2024
$55K round led by Digital Africa
Valorigo Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Valorigo's valuation, stock price, and market status.